es
Feedback

¡No caigas en manos de tramposos! Telemetrio encuentra y marca estos canales 👉 Si quieres ver la etiqueta, suscríbete

️Macro Alpha Analytics🫆

️Macro Alpha Analytics🫆

Ir al canal en Telegram

欢迎加入 【Macro Alpha Analytics】 ​⚖️ 法律声明 : ​📌 分享性质: 本群所有观点纯属个人意见分享,不构成买卖建议 (No Buy/Sell Recommendation)。 📌 专业咨询: 在做出任何投资决定前,请务必咨询专业持牌理财顾问或您的股票经纪。 📌 责任豁免: 阁下须对自身的财务决策负全责。本群不对任何投资亏损、交易风险或决策后果承担任何法律责任。 ⚠️ 风险提示: 市场波动无常,投资需根据自身财务承受能力审慎操作。 ​

Mostrar más
6 444
Suscriptores
Sin datos24 horas
-307 días
-14730 días
Archivo de publicaciones
photo content
08 dic 2024, 04:05

photo content
08 dic 2024, 02:14

PM: Significant increase in tech sector investments should benefit local firms https://theedgemalaysia.com/node/736941
08 dic 2024, 00:51

A right stock is enough to change one's life ✅
08 dic 2024, 00:15

photo content
07 dic 2024, 22:37

photo content
07 dic 2024, 22:21

Exploring new opportunities https://theedgemalaysia.com/node/736931
07 dic 2024, 21:09

据说课程费用高达六位数
据说课程费用高达六位数
07 dic 2024, 20:13

07 dic 2024, 07:08

#Integrity
#Integrity
06 dic 2024, 23:50

PM to launch Penang Silicon Design @5km+ to boost integrated circuit design ecosystem https://theedgemalaysia.com/node/736929
06 dic 2024, 23:50

杨忠礼电力数据中心 首阶段已启用 https://www.enanyang.my/node/639068
06 dic 2024, 04:07

CPOPC:大马印尼产量停滞 明年棕油价上看5000令吉 https://www.enanyang.my/node/639062
06 dic 2024, 03:23

台积电稳居老大 晶圆代工市占65%再创高 | 财经 | 東方網 馬來西亞東方日報 https://www.orientaldaily.com.my/news/business/2024/12/06/697915
06 dic 2024, 01:59

国家队鼎力撑盘后,也会顾及大局,他们买入这样多的货,不会自己炸自己的。
06 dic 2024, 01:22

地表最强的国家队☺️ 靠他们好过靠外资 ✅
06 dic 2024, 01:06

Key takeaways from VSI briefing: Guidance for FY25: Revised upwards sales to RM4.5b (from RM4.2b). Expect better 2QFY25 but a much stronger 2HFY25 due to ramp-up of all new models across key customers.* May not be able to hit 5% net margin but hopeful to do 4%. Forecasted sales breakdown: Coffee brewer RM700m, pool RM400m, US customer RM500m, Indo RM300m, Customer X RM1.85b (not inc Philippines) & others Potential Customer A medical customer. Very confident to secure it soon just that there is a delay in the product launch. In terms of revenue, not much impact but will be a big boost in securing more contracts in this segment (which requires tedious process with approval with FDA). Update in Philippines To recap secured two models and bidding for another model. Capex RM100m. To commerce mass production by 2QCY25. Full revenue approx RM800m-1b per year.
05 dic 2024, 22:42